FDA Alerts

FDA alert
fda
FDA alert
First Oral Treatment Approved to Treat Moderate, Severe Crohn Disease
05/25/2023
Jessica Ganga
After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.
05/25/2023
FDA Alert
fda
FDA Alert
FDA Approves First Treatment of Agitation in Patients With Alzheimer Dementia
05/15/2023
Jessica Ganga
Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
05/15/2023
FDA alert
fda
FDA alert
FDA Approves the First RSV Vaccine For Use in United States
05/04/2023
Jessica Ganga
After an ongoing study, the FDA approves the first vaccine for the highly contagious respiratory virus for us in the United States.
05/04/2023
FDA ALERT
medication
FDA ALERT
FDA Approves First Treatment for Rare, Degenerative Disease
04/18/2023
Jessica Ganga
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
04/18/2023
FDA Alerts
FDA Alerts
FDA Approves Over-The-Counter Naloxone Spray for Opioid Overdoses
04/03/2023
Jessica Ganga
The FDA approves the overdose medication for over-the-counter use after data supports its safe use.
04/03/2023
Enzyme Replacement Therapy
Enzyme Replacement Therapy
First Enzyme Replacement Therapy to Treat Rare Genetic Disorder Approved
03/17/2023
Jessica Ganga
Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.
03/17/2023
FDA alert
FDA
FDA alert
FDA Approves First Oral Treatment for CKD-Caused Anemia for Adults on Dialysis
02/08/2023
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
02/08/2023
FDA ALERTS
FDA ALERTS
FDA Approves First Combination Inhaled Corticosteroid for Asthma
01/27/2023
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
01/27/2023
Treatment
Treatment
FDA Accelerates Approval for New Alzheimer Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
medication
medication
FDA Approves New HIV Medication
01/09/2023
The FDA has approved a new HIV medication for use in certain patients who are unable to be successfully treated with other approved HIV medications.
01/09/2023